Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal neutral ceramidase exacerbates MASH pathogenesis.

eGastroenterology·2026
Same author

Illustration of the gut-immune-liver axis in early-stage alcohol-related liver disease: role and non-invasive potentiation of biomarkers and peptidomic signatures.

Npj gut and liver·2026
Same author

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same author

Dietary fructose promotes MASH/HCC progression through enhanced intestinal HIF-2α-dependent iron absorption.

bioRxiv : the preprint server for biology·2026
Same author

Navigating PrEP alongside high-risk drinking: Multilevel barriers, care disruption, and intervention pathways in Kentucky.

Journal of substance use and addiction treatment·2026
Same author

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients with Severe Alcohol-associated Hepatitis.

Clinical and translational gastroenterology·2026
Same journal

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C.

Current hepatitis reports·2020
Same journal

Managing Hepatitis C in Users of Illicit Drugs.

Current hepatitis reports·2013
Same journal

DILI: New Insights into Diagnosis and Management.

Current hepatitis reports·2013
Same journal

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

Current hepatitis reports·2013
Same journal

Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant.

Current hepatitis reports·2012
Same journal

New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.

Current hepatitis reports·2012
See all related articles

Related Experiment Video

Updated: May 10, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Alcoholic Hepatitis: Steroids vs. Pentoxifylline.

Laura Smart1, Leila Gobejishvili, Neil Crittenden

  • 1Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, School of Medicine, Louisville, KY 40202 ; Department of Medicine, University of Louisville, School of Medicine, Louisville, KY 40202.

Current Hepatitis Reports
|June 11, 2013
PubMed
Summary
This summary is machine-generated.

Alcoholic hepatitis (AH) is a serious liver condition. This review explores current understanding and therapies for AH, including steroids and pentoxifylline, to improve patient outcomes.

Keywords:
Alcoholic HepatitisPentoxifyllineSteroid ResistanceSteroids

Related Experiment Videos

Last Updated: May 10, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Alcoholic hepatitis (AH) causes significant liver disease morbidity and mortality.
  • Increasing AH incidence in Europe necessitates novel therapeutic strategies.
  • Existing research faces barriers, including limited translational studies and combination therapy trials.

Purpose of the Study:

  • To review the mechanisms and therapeutic rationale for steroids and pentoxifylline in AH.
  • To discuss current challenges and future directions in AH treatment.
  • To highlight advances in understanding AH pathogenesis and management.

Main Methods:

  • Literature review of existing studies on AH mechanisms and therapies.
  • Analysis of the role of steroids and pentoxifylline in AH treatment.
  • Discussion of translational research, combination therapies, and prognostic indicators.

Main Results:

  • Steroids and pentoxifylline are established therapies with specific mechanisms of action.
  • Significant gaps exist in understanding steroid non-responsiveness and developing non-invasive endpoints.
  • Advances in AH research provide a foundation for future therapeutic development.

Conclusions:

  • Despite challenges, progress has been made in understanding AH mechanisms.
  • Steroids and pentoxifylline remain key therapeutic options.
  • Further research is crucial for developing more effective AH treatments and improving patient survival.